Gene Expression Profile of Dendritic Cell-Tumor Cell Hybrids Determined by Microarrays and Its Implications for Cancer Immunotherapy
Background. Dendritic cell- (DC-) tumor fusion cells stimulate effective in vivo antitumor responses. However, therapeutic approaches are dependent upon the coadministration of exogenous 3rd signals. The purpose of this study was to determine the mechanisms for inadequate 3rd signaling by electrofus...
Saved in:
| Main Authors: | Jens Dannull, Chunrui Tan, Christine Farrell, Cynthia Wang, Scott Pruitt, Smita K. Nair, Walter T. Lee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2015/789136 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dendritic Cell-Based Immunotherapy: The Importance of Dendritic Cell Migration
by: Min-Seon Song, et al.
Published: (2024-01-01) -
Optimal Control of Tumor Growth Model with Dendritic Cells as Immunotherapy
by: Firmansyah Reskal Motulo, et al.
Published: (2018-06-01) -
Dendritic Cell-Based Immunotherapy for Prostate Cancer
by: Hanka Jähnisch, et al.
Published: (2010-01-01) -
Cytokine-overexpressing dendritic cells for cancer immunotherapy
by: Joonsu Han, et al.
Published: (2024-12-01) -
IMMUNOTHERAPY BASED ON DENDRITIC CELLS IN BLADDER CANCER TREATMENT
by: A. S. Ilnitskaya, et al.
Published: (2018-07-01)